BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21267010)

  • 1. Clinical utility gene card for: hypertrophic cardiomyopathy (type 1-14).
    Pinto YM; Wilde AA; van Rijsingen IA; Christiaans I; Deprez RH; Elliott PM
    Eur J Hum Genet; 2011 Aug; 19(8):. PubMed ID: 21267010
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel FHL1 mutation variant identified in a patient with nonobstructive hypertrophic cardiomyopathy and myopathy - a case report.
    Giucă A; Mitu C; Popescu BO; Bastian AE; Capşa R; Mursă A; Rădoi V; Popescu BA; Jurcuţ R
    BMC Med Genet; 2020 Sep; 21(1):188. PubMed ID: 32993534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A variant of unknown significance in the GLA gene causing diagnostic uncertainty in a young female with isolated hypertrophic cardiomyopathy.
    Al-Thihli K; Ebrahim H; Hughes DA; Patel M; Tipple M; Salvarinova R; Gardiner J; Vallance H; Waters PJ
    Gene; 2012 Apr; 497(2):320-2. PubMed ID: 22336178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can genetic testing improve our aim in hypertrophic cardiomyopathy?
    Charitakis K; Basson CT
    Circ Res; 2010 May; 106(9):1446-8. PubMed ID: 20466986
    [No Abstract]   [Full Text] [Related]  

  • 5. Adverse clinical course and poor prognosis of hypertrophic cardiomyopathy due to mutations in FHL1.
    Gallego-Delgado M; Gonzalez-Lopez E; Garcia-Guereta L; Ortega-Molina M; Gonzalez-Vioque E; Cobo-Marcos M; Alonso-Pulpon L; Garcia-Pavia P
    Int J Cardiol; 2015 Jul; 191():194-7. PubMed ID: 25965631
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular autopsy and family screening in a young case of sudden cardiac death reveals an unusually severe case of FHL1 related hypertrophic cardiomyopathy.
    Gaertner-Rommel A; Tiesmeier J; Jakob T; Strickmann B; Veit G; Bachmann-Mennenga B; Paluszkiewicz L; Klingel K; Schulz U; Laser KT; Karger B; Pfeiffer H; Milting H
    Mol Genet Genomic Med; 2019 Aug; 7(8):e841. PubMed ID: 31293105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
    Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
    Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic bases of hypertrophic cardiomyopathy.
    Mattos BP
    Arq Bras Cardiol; 2002 Mar; 78(3):323-40. PubMed ID: 11998826
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hypertrophic cardiomyopathy].
    Bundgaard H; Havndrup O; Høst U; Kelbaek H
    Ugeskr Laeger; 1998 Sep; 160(38):5478-83. PubMed ID: 9763919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding the genetic spectrum of hypertrophic cardiomyopathy: X marks the spot.
    Semsarian C; Ingles J
    Circ Cardiovasc Genet; 2013 Dec; 6(6):528-30. PubMed ID: 24347617
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnostic criteria in hypertrophic cardiomyopathy--another paradigm shift.
    Mckenna WJ; Elliott PM
    Eur Heart J; 1998 Apr; 19(4):539-40. PubMed ID: 9597400
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases:hypertrophic cardiomyopathy, long-QT syndrome, and Marfan syndrome. A statement for healthcare professionals from the Councils on Clinical Cardiology, Cardiovascular Disease in the Young, and Basic Science, American Heart Association.
    Maron BJ; Moller JH; Seidman CE; Vincent GM; Dietz HC; Moss AJ; Sondheimer HM; Pyeritz RE; McGee G; Epstein AE
    Circulation; 1998 Oct; 98(14):1460-71. PubMed ID: 9841131
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic testing strategies for the diagnosis of hypertrophic cardiomyopathy.
    Moura C; Leite-Moreira AF
    Rev Port Cardiol; 2011 Jan; 30(1):19-23. PubMed ID: 21425740
    [No Abstract]   [Full Text] [Related]  

  • 14. DNA testing in familial hypertrophic cardiomyopathy: clinical and laboratory implications.
    Smart RV; Yu B; Le H; French JA; Richmond DR; Jeremy RW; Semsarian C; Cheung L; Ross DA; Trent RJ
    Clin Genet; 1996 Oct; 50(4):169-75. PubMed ID: 9001794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic testing for familial hypertrophic cardiomyopathy in newborn infants. Hypertrophic cardiomyopathy can be treated but not cured.
    Goodwin JF
    BMJ; 1995 Jul; 311(6996):58. PubMed ID: 7613342
    [No Abstract]   [Full Text] [Related]  

  • 16. W4R variant in CSRP3 encoding muscle LIM protein in a patient with hypertrophic cardiomyopathy.
    Newman B; Cescon D; Woo A; Rakowski H; Erikkson MJ; Sole M; Wigle ED; Siminovitch KA
    Mol Genet Metab; 2005 Apr; 84(4):374-5. PubMed ID: 15781201
    [No Abstract]   [Full Text] [Related]  

  • 17. X-linked Recessive Distal Myopathy With Hypertrophic Cardiomyopathy Caused by a Novel Mutation in the FHL1 Gene.
    D'Arcy C; Kanellakis V; Forbes R; Wilding B; McGrath M; Howell K; Ryan M; McLean C
    J Child Neurol; 2015 Aug; 30(9):1211-7. PubMed ID: 25246303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic clues to disease pathways in hypertrophic and dilated cardiomyopathies.
    Watkins H
    Circulation; 2003 Mar; 107(10):1344-6. PubMed ID: 12642349
    [No Abstract]   [Full Text] [Related]  

  • 19. Familial hypertrophic cardiomyopathy: diagnostic and therapeutic implications of recent genetic studies.
    Bachinski LL; Roberts R
    Mol Med Today; 1996 Sep; 2(9):387-93. PubMed ID: 8885258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology of hypertrophic cardiomyopathy.
    Morita H; DePalma SR; Arad M; McDonough B; Barr S; Duffy C; Maron BJ; Seidman CE; Seidman JG
    Cold Spring Harb Symp Quant Biol; 2002; 67():383-8. PubMed ID: 12858563
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.